Actively Recruiting
Endoscopic Treatment for Zenker's Diverticulum
Led by Istituto Clinico Humanitas · Updated on 2022-09-21
400
Participants Needed
1
Research Sites
1043 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Zenker's diverticulum (ZD) is a rare benign condition, due to an acquired sac-like outpouching of the mucosa and submucosa layers originating from the pharyngoesophageal junction. Endoscopic techniques like flexible endoscopic septum division (FESD) or per-oral endoscopic septotomy (POES), represent a minimally invasive alternative to surgery or to rigid endoscopic procedure to treat ZD. The goal of the research will be to evaluate the safety of the procedures and to measure Zenker-symptom severity in all patients treated by endoscopic procedures.
CONDITIONS
Official Title
Endoscopic Treatment for Zenker's Diverticulum
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with symptomatic Zenker's diverticulum treated by endoscopic procedures
You will not qualify if you...
- Pregnancy
- Breastfeeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Humanitas Research Hospital
Rozzano, Italy, 20089
Actively Recruiting
Research Team
A
Alessandro Repici, Prof.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here